Baird Medical Investment Holdings Ltd - Ordinary Share (BDMD) share price
Baird Medical Investment Holdings Ltd - Ordinary Share (NASDAQ:BDMD) last traded at $0.09, down 44.13% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.00B and a 52-week range of $0.07 to $3.7.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $0.09 |
| 1-day move | -44.13% |
| 52-week range | $0.07 - $3.7 |
| Market cap | $0.00B |
| From 52-week high | -97.60% |
| Volume vs average | 3.5x |
| Falling Shares risk score | 80/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Baird Medical Investment Holdings Ltd - Ordinary Share falling today?
Baird Medical Investment Holdings Ltd - Ordinary Share (NASDAQ:BDMD) is down 44.13% at its latest quote and trades 97.6% below its 52-week high, on volume 3.5x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Baird Medical Investment Holdings Ltd - Ordinary Share share price today?
Baird Medical Investment Holdings Ltd - Ordinary Share (NASDAQ:BDMD) last traded at $0.09, a -44.13% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Baird Medical Investment Holdings Ltd - Ordinary Share?
Baird Medical Investment Holdings Ltd - Ordinary Share's 52-week low is $0.07 and its 52-week high is $3.7; the shares trade 97.6% below the high.
What is the market cap of Baird Medical Investment Holdings Ltd - Ordinary Share?
Baird Medical Investment Holdings Ltd - Ordinary Share has a market capitalisation of about $0.00B at the latest price.
What are the risks of investing in Baird Medical Investment Holdings Ltd - Ordinary Share?
Falling Shares Intelligence rates Baird Medical Investment Holdings Ltd - Ordinary Share 80/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com